SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
afatinib
Lv4
1
620 积分
2022-04-27 加入
最近求助
最近应助
互助留言
Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
11天前
已完结
Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy
11天前
已完结
LBA58 Pathological response to neoadjuvant tislelizumab (TIS) plus platinum-doublet (PtDb) chemotherapy (CT) in resectable stage II-IIIA NSCLC patients (pts) in the phase III (Ph3) RATIONALE-315 trial
12天前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
12天前
已完结
Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer
12天前
已完结
P15.02 Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable Non-Small Cell Lung Cancer
12天前
已完结
Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study
14天前
已完结
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
14天前
已完结
Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer
18天前
已完结
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study
18天前
已关闭
没有进行任何应助
太慢了【积分已退回】
1个月前
太慢了【积分已退回】
3个月前
找到了【积分已退回】
1年前
谢谢!
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论